Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss severity is linked to physical signs of high androgens, not blood hormone levels.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Testosterone is made by Leydig cells, is active when not bound to proteins, and works by binding to receptors in muscles and other tissues.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

A 77-year-old woman with hair loss had high testosterone and 17OH-progesterone levels, but no significant findings on imaging.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Finasteride treats hair loss and prostate issues by lowering certain hormone levels.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Quercetin may help with PCOS symptoms, but more research is needed.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Both birth control pills improved hormone levels and skin conditions in women with hyperandrogenism, but the one with drospirenone was more effective.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Androgens affect skin conditions like acne and hair loss through specific biochemical pathways.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.